Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer. (2019). Biomolecules and Biomedicine, 19(3), 227-233. https://doi.org/10.17305/bjbms.2019.4204